Pathology Institute 2012

Subscriber Login

Login
G2IQ Logo
G2 Intelligence
  • Lifepoint Ad
  • LIR Sample Issue Ad
Ezine Sign-up
FREE e-zine for diagnostics pros. Subscribe now to this weekly email featuring G2's proprietary findings.
Subscribe

Upcoming G2 Events

Pathology Institute 2012
February 9-10, 2012
The Westin Beach Resort & Spa
Fort Lauderdale, FL
Molecular Diagnostics – Spring
April 17-19, 2012
Fairmont Copley Plaza
Boston, MA

G2 Research

Diagnostics Market Analysis and Trends

Research

Lab Industry Strategic Outlook 2011: Market Trends & Analysis
Lab Industry Strategic Outlook 2011: Market Trends & Analysis
Lab Industry Analysis 2010: Test Volumes, Revenues, and Category Leaders Lab Industry Analysis 2010: Test Volumes, Revenues, and Category Leaders
U.S. Laboratory Reference Testing - Market Profile & Pricing Trends 2010
U.S. Laboratory Reference Testing - Market Profile & Pricing Trends 2010

Events

Molecular Diagnostics – Spring
April 17-19, 2012 - Boston, MA

Features & Analysis

»2011 a Mixed Year for Diagnostics Industry
The year 2011 was a tumultuous one for the diagnostics industry. Some companies were able to thrive with record revenue growth and an increasingly promising pipeline, while others saw revenues plummet and stock prices tumble under the pressure of global economic uncertainties.
more…
Copyright © 2012 Kennedy Information, LLC

Laboratory Business Strategy and Operations

Research

Value Driven Lab
Creating a Value-Driven Laboratory: Opportunities in the New Marketplace
How to Build an MDx Lab
How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations
Healthcare Market Reforms
Health Care Market Reforms: Implications and Prescriptions for Laboratories
Sales Compensation in the Laboratory Industry: Incentives, Plans and Strategies
Sales Compensation in the Laboratory Industry: Incentives, Plans and Strategies

Events

Pathology Institute 2012
February 9-10, 2012 - Fort Lauderdale, FL

Features & Analysis

»FTC Approves LabCorp’s Acquisition of Orchid Cellmark But With Conditions
Following numerous extensions of its tender offer, LabCorp (Burlington, N.C.) in early December finally received approval from the Federal Trade Commission (FTC) to acquire Orchid Cellmark, but only under certain conditions.
more…
Copyright © 2012 Kennedy Information, LLC

Diagnostics Regulation, Compliance and Risk

Reference

2011 Medicare Reimbursement Manual for Laboratory & Pathology Services
2011 Medicare Reimbursement Manual for Laboratory & Pathology Services
CLIA Compliance: The Essential Reference for the Clinical Laboratory, 3rd Edition CLIA Compliance: The Essential Reference for the Clinical Laboratory, 3rd Edition

Events

Webinar – CLIA Compliance, PT and Quality Control: What’s New for 2012?
Wednesday, March 7, 2012 2:00 p.m. - 3:30 p.m.

Features & Analysis

»Congress Defers Medicare Physician Pay Cut for Two Months; Last-Minute Deal Also Extends Pathology Grandfather Protection
In last-minute maneuverings, Congressional lawmakers Dec. 23 approved an amended version of payroll tax legislation that also would defer for two months a Medicare pay cut for physicians that had been due to be implemented Jan. 1.
more…
Copyright © 2012 Kennedy Information, LLC
Creatign a Value Driven Lab

Lab and Pathology Free Newsletter
G2's FREE, weekly email gives you access to G2 market analysis, regulatory changes, M&A activity, leadership moves and more on the diagnostics industry. Recent articles include:

  • »AMA to Congress: ‘Stop Switch to ICD-10’
    Jim Curren, Editor, National Intelligence Report
    The American Medical Association (AMA) is calling on Congress to halt the implementation of ICD-10 diagnosis and procedural code sets, set to begin Oct. 1, 2013, and to work with stakeholders to craft an alternative.
    more…
  • »Mitt Romney Taking Heat Over Damon Involvement
    By Kimberly Scott, Managing Editor, G2 Intelligence
    Mitt Romney is taking a lashing once again for his role at Damon Corp., a medical testing company that paid more than $119 million in criminal and civil fines related to Medicare fraud while he served on the board. And the lashing is coming from both parties.
    more…
  • »Industry Executive Move: Roche Applied Science

    Roche Diagnostics has announced that Dan Zabrowski will head Roche Applied Science in the Diagnostics Division, effective Feb. 1. He succeeds Paul Brown, who has led Roche Applied Science since September 2011.

    more…
More Insider Subscribe
Lab and Pathology Wire Logo

G2's FREE, daily email service brings you up-to-the-minute lab and diagnostics industry news from from across the spectrum of providers.
Subscribe
  • MDX Tower Ad
Advertising | Privacy | Sitemap
G2 Intelligence © 2012 Kennedy Information, LLC
Phone: 800.401.5937 or +1.973.718.4700
All Rights Reserved.
|
»